Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial.

Henry, R R; Gumbiner, B; Ditzler, T; Wallace, P; Lyon, R; Glauber, H S
Diabetes care; 1993 Jan;16(1):21-31. PMID: 8422777
Department of Medicine, University of California, San Diego.


To determine whether tight glycemic control can be obtained using intensive conventional split-dose insulin therapy in the outpatient management of type II diabetes without development of unacceptable side effects.